Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2024
- #389
- Final score
- 52.86
- Years on list
- 5
↘ Down 22 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 22 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 316 since 2021
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 25 since 2023
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | CTLT | RGEN | RVTY |
|---|---|---|---|
| Climate Change | — | 65.6 | 56.7 |
| Employee Relations | — | 37.8 | 59.0 |
| Environment | — | 57.0 | 55.4 |
| Stakeholders & Society | — | 49.6 | 54.7 |
| Human Rights | — | 52.4 | 51.0 |
| Governance | — | 38.6 | 50.9 |
| Performance Rating | — | 49.0 | 55.0 |